Clinical Evaluation of Serum Tumor Markers in Patients With Advanced-Stage Non-Small Cell Lung Cancer Treated With Palliative Chemotherapy in China.

导出 LinkOut

翻译打印收藏纠错

作者： Muhammad,Abbas ^[1] ; Said Abasse,Kassim ^[2] ; Murad,Habib ^[3] ; Xiaoyou,Li ^[4] ; Meiqi,Shi ^[2] ; Zhong-Chang,Wang ^[2] ; Yiqiao,Hu ^[1] ; Hai-Liang,Zhu ^[1]

作者单位： State Key Laboratory of Pharmaceutical Biotechnology, Institute of Artificial Intelligence Biomedicine, Nanjing University, Nanjing, China. ^[1] Department of Medical Oncology, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research and Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China. ^[2] Centre de Recherche en Gestion des Services de Sante, Faculté des Sciences de L'administration (FSA), Université Laval (UL), Centre Hospitalière Universitaire (CHU) de Québec UL-IUCPQ-UL, Québec, QC, Canada. ^[3] Department of Surgery, Ayub Medical College, Abbottabad, Pakistan. ^[4] Institute of Drug R&D, Medical School of Nanjing University, Nanjing, China. ^[5]

关键词 non-small cell lung cancer palliative chemotherapy prognosis serum tumor markers six-cycles stage IV

DOI 10.3389/fonc.2020.00800

PMID 32582542

发布时间 2020-09-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Frontiers in oncology

2020年10卷

800页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Clinical Evaluation of Serum Tumor Markers in Patients With Advanced-Stage Non-Small Cell Lung Cancer Treated With Palliative Chemotherapy in China.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Clinical Evaluation of Serum Tumor Markers in Patients With Advanced-Stage Non-Small Cell Lung Cancer Treated With Palliative Chemotherapy in China.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

检索历史清除